相关实验视频

Updated: Jun 5, 2025

Histological Quantification of Chronic Myocardial Infarct in Rats

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

急性心肌梗塞中受调节的细胞死亡:分子机制和治疗含义

Lili Zhu¹, Yiyang Liu², Kangkai Wang²

¹Department of Pathology, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Ageing research reviews

|December 7, 2024

概括

急性心肌梗塞 (AMI) 涉及细胞死亡途径,使心脏损伤恶化. 针对这些调节细胞死亡 (RCD) 机制为心脏病发作患者提供了新的治疗策略.

科学领域:

心血管研究研究心血管研究
分子生物学分子生物学
心血管疾病的发病因子

背景情况:

急性心肌梗塞 (AMI) 源于冠状动脉样硬化,导致缺血和缺氧.
心肌缺血/反 (I/R) 损伤会加剧心脏损伤,损害心脏功能并增加并发症的风险.
调节细胞死亡 (RCD) 途径是AMI病原体的核心.

研究的目的:

系统地审查AMI中的RCD机制.
通过RCD的透视来探索AMI病变的发生.
为了确定AMI管理的潜在治疗目标.

主要方法:

在AMI中对RCD途径的文献综述.
在RCD中分析分子调节机制.
治疗目标的识别和评估.

主要成果:

多个RCD路径有助于AMI.
关键的分子效应器编排RCD.
抑制特定的分子标可能会限制心肌细胞损失和纤维化.

结论:

了解RCD机制对于AMI治疗至关重要.
准RCD的分子调节器是一个有前途的治疗途径.
本文重点介绍了革新AMI管理的新策略.

关键词:

剧烈的心肌梗塞急性心肌梗塞分子机制的分子机制调节的细胞死亡.治疗含义的治疗影响.

更多相关视频

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

相关概念视频

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...